Pages that link to "Q33274430"
Jump to navigation
Jump to search
The following pages link to HOXB13-to-IL17BR expression ratio is related with tumor aggressiveness and response to tamoxifen of recurrent breast cancer: a retrospective study (Q33274430):
Displaying 50 items.
- Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response (Q27694612) (← links)
- Breast cancer classification and prognostication through diverse systems along with recent emerging findings in this respect; the dawn of new perspectives in the clinical applications (Q30245184) (← links)
- Genomancy: predicting tumour response to cancer therapy based on the oracle of genetics. (Q30440216) (← links)
- Risk estimation of distant metastasis in node-negative, estrogen receptor-positive breast cancer patients using an RT-PCR based prognostic expression signature (Q30854643) (← links)
- Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus (Q33641475) (← links)
- HOXB9, a gene overexpressed in breast cancer, promotes tumorigenicity and lung metastasis (Q33666849) (← links)
- Genomic distance entrained clustering and regression modelling highlights interacting genomic regions contributing to proliferation in breast cancer (Q33687781) (← links)
- Epigenetic repression of the estrogen-regulated Homeobox B13 gene in breast cancer (Q33974237) (← links)
- Predictive relevance of HOXB13 protein expression for tamoxifen benefit in breast cancer (Q34173474) (← links)
- Positive cross-talk between estrogen receptor and NF-kappaB in breast cancer (Q34374852) (← links)
- Clinical significance of the nuclear receptor co-regulator DC-SCRIPT in breast cancer: an independent retrospective validation study. (Q34613612) (← links)
- Microarrays in the 2010s: the contribution of microarray-based gene expression profiling to breast cancer classification, prognostication and prediction (Q35558070) (← links)
- Early developments in gene-expression profiling of breast tumors: potential for increasing black-white patient disparities in breast cancer outcomes? (Q35622059) (← links)
- A role for estrogen receptor phosphorylation in the resistance to tamoxifen (Q35684445) (← links)
- Analysis of the Hox epigenetic code (Q35926749) (← links)
- HOXB7-S3 inhibits the proliferation and invasion of MCF-7 human breast cancer cells (Q36089916) (← links)
- Prediction and prognosis: impact of gene expression profiling in personalized treatment of breast cancer patients (Q36117673) (← links)
- Urinary Nucleic Acid TSPAN13-to-S100A9 Ratio as a Diagnostic Marker in Prostate Cancer (Q36400527) (← links)
- The HOXB13 p.Gly84Glu mutation is not associated with the risk of breast cancer (Q36438352) (← links)
- Mechanisms of resistance to endocrine therapy in breast cancer: focus on signaling pathways, miRNAs and genetically based resistance. (Q36589865) (← links)
- Re-evaluating early breast neoplasia (Q36643056) (← links)
- HOXB13:IL17BR and molecular grade index and risk of breast cancer death among patients with lymph node-negative invasive disease. (Q36903062) (← links)
- A role for biomarkers in the screening and diagnosis of breast cancer in younger women. (Q36950426) (← links)
- Cytochrome P450 2D6 and homeobox 13/interleukin-17B receptor: combining inherited and tumor gene markers for prediction of tamoxifen resistance (Q37000701) (← links)
- Recurrent HOXB13 mutations in the Dutch population do not associate with increased breast cancer risk (Q37101570) (← links)
- Gene expression profiling: changing face of breast cancer classification and management (Q37169835) (← links)
- Current molecular diagnostics of breast cancer and the potential incorporation of microRNA (Q37378012) (← links)
- Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients. (Q37444430) (← links)
- CITED2 and NCOR2 in anti-oestrogen resistance and progression of breast cancer. (Q37457732) (← links)
- Genomic predictors of outcome and treatment response in breast cancer (Q37523889) (← links)
- Preinvasive breast cancer (Q37569919) (← links)
- HOXB13 mediates tamoxifen resistance and invasiveness in human breast cancer by suppressing ERα and inducing IL-6 expression (Q37668201) (← links)
- The Hox genes and their roles in oncogenesis. (Q37722452) (← links)
- Molecular Predictors of Response to Therapy for Breast Cancer (Q37856117) (← links)
- Impact of the 21-Gene Recurrence Score Assay Compared With Standard Clinicopathologic Guidelines in Adjuvant Therapy Selection for Node-Negative, Estrogen Receptor-Positive Breast Cancer (Q37871407) (← links)
- Engrailed homeobox transcription factors as potential markers and targets in cancer. (Q38080336) (← links)
- Important and critical scientific aspects in pharmacogenomics analysis: lessons from controversial results of tamoxifen and CYP2D6 studies (Q38105253) (← links)
- Two-gene expression ratio as predictor for breast cancer treated with tamoxifen: evidence from meta-analysis (Q38165072) (← links)
- EN2: a novel prostate cancer biomarker (Q38165246) (← links)
- Molecular tests as prognostic factors in breast cancer (Q38184381) (← links)
- Indications for prognostic gene expression profiling in early breast cancer (Q38451798) (← links)
- Gene-Expression-Based Predictors for Breast Cancer (Q38555220) (← links)
- Functional characterization of the HOXB13 promoter region (Q40030116) (← links)
- Decreased expression of ABAT and STC2 hallmarks ER-positive inflammatory breast cancer and endocrine therapy resistance in advanced disease (Q41136265) (← links)
- Potential utility of an expression array signature for predicting anthracycline responsiveness or resistance (Q43067630) (← links)
- Oncoprotein HBXIP enhances HOXB13 acetylation and co-activates HOXB13 to confer tamoxifen resistance in breast cancer (Q50301832) (← links)
- Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? (Q51912002) (← links)
- HOXD10 expression in human breast cancer. (Q54196355) (← links)
- Molecular prognostic and predictive markers of breast cancer treatment (Q54403385) (← links)
- Gene Expression Profiling in Breast Cancer and Its Effect on Therapy Selection in Early-Stage Breast Cancer (Q57116157) (← links)